AbbVie Inc. Shares Outstanding (Cover Page)
AbbVie Inc. (ABBV) had Shares Outstanding (Cover Page) of 1.77 billion shares as of 2026-07-27, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-27: Entity Common Stock, Shares Outstanding 1.77B shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 1.77B shares.
- 2026-02-10: Entity Common Stock, Shares Outstanding 1.77B shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 1.77B shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 1.77B shares 10-Q · filed 2026-08-03 |
| 2026-04-28 | 1.77B shares 10-Q · filed 2026-05-08 |
| 2026-02-10 | 1.77B shares 10-K · filed 2026-02-20 |
| 2025-10-27 | 1.77B shares 10-Q · filed 2025-11-04 |
| 2025-07-29 | 1.77B shares 10-Q · filed 2025-08-04 |
| 2025-04-30 | 1.77B shares 10-Q · filed 2025-05-09 |
| 2025-01-31 | 1.77B shares 10-K · filed 2025-02-14 |
| 2024-10-28 | 1.77B shares 10-Q · filed 2024-11-04 |
| 2024-07-29 | 1.77B shares 10-Q · filed 2024-08-07 |
| 2024-04-25 | 1.77B shares 10-Q · filed 2024-05-03 |
| 2024-01-31 | 1.77B shares 10-K · filed 2024-02-20 |
| 2023-10-27 | 1.77B shares 10-Q · filed 2023-11-06 |
| 2023-07-31 | 1.77B shares 10-Q · filed 2023-08-07 |
| 2023-04-25 | 1.76B shares 10-Q · filed 2023-05-05 |
| 2023-01-31 | 1.77B shares 10-K · filed 2023-02-17 |
| 2022-10-26 | 1.77B shares 10-Q · filed 2022-11-04 |
| 2022-07-27 | 1.77B shares 10-Q · filed 2022-08-04 |
| 2022-04-27 | 1.77B shares 10-Q · filed 2022-05-06 |
| 2022-01-31 | 1.77B shares 10-K · filed 2022-02-18 |
| 2021-10-25 | 1.77B shares 10-Q · filed 2021-11-02 |
| 2021-07-26 | 1.77B shares 10-Q · filed 2021-08-02 |
| 2021-04-28 | 1.77B shares 10-Q · filed 2021-05-07 |
| 2021-01-31 | 1.77B shares 10-K · filed 2021-02-19 |
| 2020-10-27 | 1.77B shares 10-Q · filed 2020-11-04 |
| 2020-07-28 | 1.76B shares 10-Q · filed 2020-08-04 |
| 2020-04-30 | 1.48B shares 10-Q · filed 2020-05-08 |
| 2020-01-31 | 1.48B shares 10-K · filed 2020-02-21 |
| 2019-10-29 | 1.48B shares 10-Q · filed 2019-11-06 |
| 2019-07-29 | 1.48B shares 10-Q · filed 2019-08-05 |
| 2019-04-26 | 1.48B shares 10-Q · filed 2019-05-03 |
| 2019-02-08 | 1.48B shares 10-K · filed 2019-02-27 |
| 2018-10-31 | 1.50B shares 10-Q · filed 2018-11-07 |
| 2018-07-31 | 1.51B shares 10-Q · filed 2018-08-07 |
| 2018-04-27 | 1.59B shares 10-Q · filed 2018-05-04 |
| 2018-02-02 | 1.59B shares 10-K · filed 2018-02-16 |
| 2017-10-24 | 1.60B shares 10-Q · filed 2017-11-07 |
| 2017-07-24 | 1.59B shares 10-Q · filed 2017-08-07 |
| 2017-04-24 | 1.59B shares 10-Q · filed 2017-05-05 |
| 2017-01-31 | 1.59B shares 10-K · filed 2017-02-17 |
| 2016-10-24 | 1.63B shares 10-Q · filed 2016-11-07 |
| 2016-06-30 | 1.63B shares 10-Q · filed 2016-08-05 |
| 2016-03-31 | 1.62B shares 10-Q · filed 2016-05-06 |
| 2016-01-31 | 1.61B shares 10-K · filed 2016-02-19 |
| 2015-09-30 | 1.63B shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 1.66B shares 10-Q · filed 2015-08-07 |
| 2015-03-31 | 1.59B shares 10-Q · filed 2015-05-08 |
| 2015-01-31 | 1.59B shares 10-K · filed 2015-02-20 |
| 2014-09-30 | 1.59B shares 10-Q · filed 2014-11-07 |
| 2014-06-30 | 1.59B shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 1.59B shares 10-Q · filed 2014-05-09 |
| 2014-01-31 | 1.59B shares 10-K · filed 2014-02-21 |
| 2013-09-30 | 1.59B shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 1.59B shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 1.58B shares 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |